Synektik S.A. Logo

Synektik S.A.

Manufactures radiopharma; provides medical equipment, IT solutions, and services to specialists.

SNT | WAR

Overview

Corporate Details

ISIN(s):
PLSNKTK00019
LEI:
259400U0O19JWLVHQN14
Country:
Poland
Address:
WARSZAWA JÓZEFA PIUSA DZIEKOŃSKIEGO 3, 00-728 WARSZAWA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Synektik S.A. is a provider and integrator of innovative solutions for the medical sector, with a focus on radiology, oncology, cardiology, and neurology. The company's core operations include the manufacturing of radiopharmaceuticals, the supply and service of advanced medical equipment, and the development of specialized IT solutions. Synektik supports medical facilities with products and services used in diagnostic imaging, nuclear medicine, and surgery, aiming to implement and disseminate modern medical technologies. The company also provides comprehensive maintenance for medical devices and IT infrastructure.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-09 09:16
Regulatory News Service
Wybrane dane operacyjne segmentu sprzedaży sprzętu, rozwiązań IT oraz usług - C…
Polish 1.4 KB
2025-09-29 13:34
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.7 KB
2025-09-23 14:05
Board/Management Information
życiorys nowego Członka Zarządu
Polish 92.3 KB
2025-09-23 14:05
Board/Management Information
Powołanie nowego Członka Zarządu - Content (PL)
Polish 1.2 KB
2025-09-16 16:47
Related Party Transaction
Uzupełnienie informacji o zawarciu istotnej umowy sprzedaży systemu robotyczneg…
Polish 1.3 KB
2025-09-16 15:04
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.8 KB
2025-09-16 13:26
Related Party Transaction
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.5 KB
2025-09-12 09:23
Related Party Transaction
Informacja o zawarciu istotnej umowy dot. udzielenia licencji na produkcję Glun…
Polish 1.8 KB
2025-09-10 10:57
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.6 KB
2025-09-03 09:15
Audit Report / Information
Opinia Biegłego
Polish 344.4 KB
2025-09-03 09:15
M&A Activity
Plan Podziału
Polish 1.6 MB
2025-09-03 09:15
Legal Proceedings Report
Opinia biegłego rewidenta z badania Planu Podziału - Content (PL)
Polish 1.8 KB
2025-08-12 12:00
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży - Content (PL)
Polish 2.1 KB
2025-08-11 08:29
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.6 KB
2025-08-08 15:37
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.6 KB

Automate Your Workflow. Get a real-time feed of all Synektik S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Synektik S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Develops DNA vaccines and therapeutics for companion animals and livestock.
South Korea 222670
Pluri Inc. Logo
Develops placenta-based cell therapeutics using a proprietary 3D cell-expansion platform.
Israel PLUR
A global supplier of generic APIs using AI to accelerate drug development.
South Korea 041910
Poltreg S.A. Logo
Pioneering T-regulatory cell therapies for autoimmune diseases like diabetes, MS, and ALS.
Poland PTG
PolyPeptide Group AG Logo
A global CDMO specializing in peptide and oligonucleotide APIs for pharma and biotech partners.
Switzerland PPGN
Develops sensitive point-of-care biomarker diagnostics for human and animal health.
South Korea 335810
A global CDEMO offering end-to-end solutions for antibody therapeutics and biologics.
South Korea 334970
Develops affordable biosimilars and novel antibody drugs for life-threatening diseases.
Singapore 950210
Develops protein-based immunotherapies for metabolic diseases, immune disorders, and cancer.
South Korea 296160
PROTEINA CO.,LTD. Logo
A biotech firm specializing in proteomics for drug discovery and diagnostics in oncology.
South Korea 468530

Talk to a Data Expert

Have a question? We'll get back to you promptly.